Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annalisa Gaimarri"'
Autor:
Cecilia Gotti, Milena Moretti, Iwo Bohr, Iryna Ziabreva, Silvia Vailati, Renato Longhi, Loredana Riganti, Annalisa Gaimarri, Ian G. McKeith, Robert H. Perry, Dag Aarsland, Jan Petter Larsen, Emanuele Sher, Ruth Beattie, Francesco Clementi, Jennifer A. Court
Publikováno v:
Neurobiology of Disease, Vol 23, Iss 2, Pp 481-489 (2006)
Antibodies raised against human α2-6 and β2-4 nicotinic receptor subunits were utilized to fractionate 3H-epibatidine binding in human temporal cortex and striatum. The predominant receptor subtypes in both regions contained α4 and β2 subunits. I
Externí odkaz:
https://doaj.org/article/58d26e8963cd4e5683a49d3e74863539
Autor:
Cecilia Gotti, Patrizia Pedrazzi, Irene Manfredi, Luca Pucci, Milena Moretti, Annalisa Gaimarri, Stefania Guiducci, Francesco Clementi, Michele Zoli, Alice Fornari
Publikováno v:
Biochemical Pharmacology; Vol 78
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated ion channels present in the central and peripheral nervous systems, that are permeable to mono- and divalent cations. They share a common basic structure but their pharm
Autor:
Cecilia Gotti, Francesco Clementi, Cosetta Matteoni, Loredana Riganti, Annalisa Gaimarri, Silvia Di Angelantonio, Andrea Nistri, Caterina Canu-Boido, Fabio Sparatore
Publikováno v:
British Journal of Pharmacology. 146:1096-1109
Nicotinic drug treatment can affect the expression of neuronal nicotinic acetylcholine receptors (nAChR) both in vivo and in vitro through molecular mechanisms not fully understood. The present study investigated the effect of the novel cytisine dime
Autor:
Manolo Mugnaini, Cecilia Gotti, Francesco Clementi, Michele Zoli, Annalisa Gaimarri, Francesco Pistillo, Michela Tessari, Milena Moretti, Irene Manfredi
Publikováno v:
Molecular pharmacology. 78(2)
Long-term nicotine exposure changes neuronal acetylcholine nicotinic receptor (nAChR) subtype expression in the brains of smokers and experimental animals. The aim of this study was to investigate nicotine-induced changes in nAChR expression in two m
Autor:
Allan C. Collins, Cecilia Gotti, Michael J. Marks, Annalisa Gaimarri, Francesco Clementi, Natalie M. Meinerz, Milena Moretti
Publikováno v:
Molecular pharmacology. 73(6)
Alpha4 and beta2 nicotinic cholinergic receptor (nAChR) subunits can assemble in heterologous expression systems as pentameric receptors with different subunit stoichiometries that exhibit differential sensitivity to activation by acetylcholine, yiel
Autor:
Milena Moretti, Alessio Zanardi, Franceso Clementi, Michele Zoli, Annalisa Gaimarri, Cecilia Gotti
Publikováno v:
Biochemical pharmacology. 74(8)
Neuronal cholinergic nicotinic receptors (nAChRs) are a heterogeneous class of cationic channels that are widely distributed in the nervous system that have specific functional and pharmacological properties. They consist of homologous subunits encod
Autor:
Milena Moretti, Alessio Zanardi, Loredana Riganti, Francesco Clementi, Annalisa Gaimarri, Cecilia Gotti
Publikováno v:
Brain research reviews. 55(1)
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of cation channels widely distributed in the brain, whose subunit composition and biophysical properties vary depending on the subtype and the area of the brain in which they are found.
Autor:
Iwo Bohr, Cecilia Gotti, Silvia Vailati, Jan Petter Larsen, Ian G. McKeith, Jennifer A. Court, Dag Aarsland, Emanuele Sher, Iryna Ziabreva, Robert H. Perry, Renato Longhi, Milena Moretti, Francesco Clementi, Loredana Riganti, Ruth E. Beattie, Annalisa Gaimarri
Publikováno v:
Neurobiology of disease 23 (2006): 481–489. doi:10.1016/j.nbd.2006.04.005
info:cnr-pdr/source/autori:Gotti C.(2); Moretti M.(2); Bohr I.(1); Ziabreva I.(1); Vailati S.(2); Longhi R.(2); Riganti L.(2); Gaimarri A.(2); McKeith I.G.(4); Perry R.H.(1); Aarsland D.; Larsen J.P.(4); Sher E.(5); Beattie R.(1); Clementi F.(2); Court J.A(1) ./titolo:Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation/doi:10.1016%2Fj.nbd.2006.04.005/rivista:Neurobiology of disease/anno:2006/pagina_da:481/pagina_a:489/intervallo_pagine:481–489/volume:23
Neurobiology of Disease, Vol 23, Iss 2, Pp 481-489 (2006)
info:cnr-pdr/source/autori:Gotti C.(2); Moretti M.(2); Bohr I.(1); Ziabreva I.(1); Vailati S.(2); Longhi R.(2); Riganti L.(2); Gaimarri A.(2); McKeith I.G.(4); Perry R.H.(1); Aarsland D.; Larsen J.P.(4); Sher E.(5); Beattie R.(1); Clementi F.(2); Court J.A(1) ./titolo:Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation/doi:10.1016%2Fj.nbd.2006.04.005/rivista:Neurobiology of disease/anno:2006/pagina_da:481/pagina_a:489/intervallo_pagine:481–489/volume:23
Neurobiology of Disease, Vol 23, Iss 2, Pp 481-489 (2006)
Antibodies raised against human alpha 2-6 and beta 2-4 nicotinic receptor subunits were utilized to fractionate H-3-epibatidine binding in human temporal cortex and striatum. The predominant receptor subtypes in both regions contained alpha 4 and bet